Connect with us

Health

IDI Awarded for Pharmacovigilance by NDA

Published

on

The Infectious Diseases Institute (IDI), Makerere University has been commended for its passion, unconditional commitment and dedicated service towards pharmacovigilance by the National Drug Authority (NDA).  Pharmacovigilance is the monitoring of the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse reactions. This award was handed over at the launch of the MedSafety App at the 3rd Annual Pharmacovigilance Stakeholders Round-table Meeting held at Golf Course Hotel on 26th February 2020.

In addition to the institutional award, top performing individuals within IDI were also awarded as follows:

  1. Dr. Arnold Arinaitwe (Accumulated the highest number of reports at a facility) 
  2. Swalha Namanda (the most cases of drug reactions reported)  
  3. Dr. Edna Auma (Constantly supports HIV vigilance, Kawaala Health Centre 4) 
  4. Dr. Bridget Ainembabazi (Recognized for the contribution towards monitoring & reporting of adverse drug reactions) 
  5. Shamim Nakadde (Recognized for the contribution towards monitoring & reporting of adverse drug reactions)

The Award presented to IDI by the National Drug Authority (NDA) in recognition of the Institute’s passion, unconditional commitment and enduring dedicated service towards pharmacovigilance, 26th February 2020, Golf Course Hotel, Kampala, Uganda.

IDI Mulago was identified among the top 10 facilities with outstanding drug reporting in Uganda and all facilities that IDI works with were selected as best in their categories (Kiswa and Kitebi). 

The Med Safety App was created to ensure that only safe drugs are maintained in circulation to the Ugandan population. The app provides an easy and convenient way for people to submit reports on the adverse reactions to drugs used, verify acknowledgment of reports and create a watch list of medication in order to receive personalised news and alerts. The reports provided are used to identify previously unknown issues with the specified medications. 

Several implementing partners attended this launch and these are; Infectious Diseases Institute, Mildmay Uganda, Medicines Transparency Alliance, Health System Advocacy Partnership, Baylor Uganda, National Medical Stores, The AIDS Support Organization, Uganda Association of Pharmacy Owners and Lung Institute. The main funders were CDC and USAID. 

MED SAFETY APP is meant to improve quality and quantity of adverse drug reporting in countries in real-time,” Dr. Yonas Tegegn Woldemariam, the WHO Country Director. 

Dr. Grace Nambatya Kyeyune, the Director of Research NDA also stated that the Med Safety App will help doctors to do timely reporting and avoid inadequacies. 

Article by Rebecca Nakitandwe, Communications Office, IDI

Continue Reading

Health

Mak’s GMI Labs Authorized to Conduct DNA Paternity Testing

Published

on

Some of the equipment used to store samples at the Makerere University Biomedical Research Centre (MakBRC), College of Health Sciences (CHS). Kampala Uganda, East Africa.

The Genomics, Molecular, and Immunology Laboratories (GMI Labs), operating under the auspices of the Makerere University Biomedical Research Center (MakBRC), have achieved another significant milestone in their journey of diagnostic excellence. The labs, renowned for their pivotal role in infectious and non-infectious disease research, have received official approval from the Director General Health Services at the Ministry of Health (MoH), Uganda, to conduct DNA Paternity Tests.

Situated at the Dept of Immunology & Molecular Biology under the School of Biomedical Sciences at the College of Health Sciences, Makerere University, the GMI Labs have been at the forefront of cutting-edge research, diagnostic testing, and training initiatives. Their remarkable contributions during the COVID-19 pandemic, where they conducted nearly a million PCR tests, underscored their unwavering commitment to public health and scientific advancement. The labs’ exemplary performance and reliability were further highlighted by their successful management of two critical COVID-19 prevalence surveys. The findings of these surveys served as foundational data for crucial decisions guiding the country’s lockdown strategies and phased reopening, earning commendation from the President and the Ministry of Health.

This latest authorization from the Ministry of Health marks a significant expansion of the GMI Labs’ diagnostic capabilities. With the approval to conduct DNA Paternity Tests, the labs are now equipped to offer a crucial service addressing the need for accurate and reliable genetic testing for determining biological parentage. In a letter dated 22nd November 2023, the Director General Health Services emphasized the laboratory’s rigorous adherence to international standards, proficiency in molecular biology techniques, and their proven track record in delivering precise and credible results. This approval further solidifies the labs’ position as a trusted institution for advanced genetic diagnostics in Uganda.

Prof. Moses L Joloba, the Director of the GMI Labs, expressed immense pride in the team’s dedication and expertise that led to this authorization. He highlighted the labs’ commitment to upholding the highest standards of ethical practice, confidentiality, and accuracy in DNA paternity testing, ensuring the delivery of dependable results crucial for legal, personal, and familial purposes.

The inclusion of DNA Paternity Testing within the GMI Labs’ list of services aligns with their overarching goal of advancing healthcare through state-of-the-art diagnostics, research, and education. This milestone represents not only a significant achievement for the labs but also a valuable resource for individuals seeking reliable and comprehensive genetic testing services. As the GMI Labs continue their unwavering commitment to excellence in healthcare and research, this new capability reaffirms their pivotal role in advancing the frontiers of molecular diagnostics and genetic testing in Uganda, working closely with reputable institutions such as Makerere University Hospital and other top-notch health facilities.

View on CHS

Continue Reading

Health

MNCH e-Post Issue 121: Learning from Nsambya Hospital Human Milk Bank to inform national scale-up & save preterm babies

Published

on

A Screenshot of Prof. Peter Waiswa during his interview with NTV. MNCH e-Post Issue No. 121, MakSPH, Makerere University, Kampala Uganda, East Africa.

Welcome to this exclusive interview with Prof. Peter Waiswa, lead expert from the Makerere University Centre of Excellence for Maternal, Newborn, and Child Health. Dr. Victoria Nakibuuka from St. Francis Nsambya Hospital, and Dr. Jesca Nsungwa from Ministry of Health Uganda. In this video, they discuss a groundbreaking innovation in Uganda’s healthcare landscape: the country’s first-ever human milk bank at St. Francis Hospital Nsambya. This initiative represents a significant stride towards improving the survival rates of premature and vulnerable infants by ensuring access to essential breast milk, even when mothers are unable to produce enough. Watch Video

Click here to View the full MNCH e-Post Issue 121

Continue Reading

Health

METS Newsletter October 2023

Published

on

Front Row (Left to Right): The hosts - Dr. Alice Namale and Ms. Evelyn Akello with Commissioner Allan Muruta and representatives from US Centers for Disease Control and Prevention (CDC) and Makerere University School of Public Health (MakSPH) enjoy a photo moment on 5th October 2023. Photo: METS. Plot 20A Kawalya Kaggwa Close, Kololo Kampala Uganda, East Africa.

The Monitoring and Evaluation Technical Support (METS) Program is a 5-year CDC-supported collaboration of Makerere University School of Public Health (MakSPH), the University of California San Francisco (UCSF) and Health Information Systems Program (HISP Uganda).

Highlights of the METS October 2023 Newsletter

  • Strategies for Enhanced Disease Surveillance and Public Health Response in Uganda
    • The MoH Department of Integrated Epidemiology Surveillance & Public Health Emergencies (IES&PHE) Head, Commissioner Allan Muruta (Dr) visited METS to acquaint himself with the various surveillance activities supported by the Program.
    • Commissioner Muruta emphasized the need to build the capacity of districts and regions to conduct surveillance activities by training the relevant staff and establishing surveillance focal points at health facility levels.
    • He further emphasized the importance of linking laboratory data to the District Health Information System (DHIS2) and ensuring that different systems are interoperable.
  • Improving quality of data for HIV testing services (HTS) through regular assessments
    • MoH has been conducting Data Quality Assessments and Improvement (DQAI) activities to inform program planning, monitoring, and performance management. HIV testing services (HTS) inter was conducted in 16 regions, 81 districts, and 111 health facilities in partnership with 26 Implementing partners.
    • The HTS DQA has improved data management, infrastructure, and understanding of indicators. Specific staff assignment at each HTS entry point has proven effective, and use of the UgandaEMR system for reporting has yielded positive results.
  • Shaping Uganda’s Healthcare Data Landscape
    • METS has maintained a strong collaboration with the Ministry of Health (MoH) providing invaluable technical support in developing various strategic guidelines for the country. These guidelines include the Uganda Health Information Exchange and Interoperability (HIE) Guidelines, the Uganda Health Data Protection and Confidentiality (HDPC) Guidelines, and the Uganda Health Data Sharing, Access, and Use Guidelines.
    • HIE and HDPC guidelines have received the endorsement of the Health Information, Innovation and Research (HIIRE) Technical Working Group (TWG), awaiting presentation to the senior management team at the MoH for final approval.
  • Empowering Health Professionals: PrEP Training in Hoima District
    • MakSPH-METS has taken a proactive stance in supporting Monitoring and Evaluation (M&E) for key populations through the development, management, and conducting trainings on the use of the PrEP tracker system across various agencies.
    • METS conducted a 5-day training on the KP/PrEP Tracker system in Hoima district. Moving forward, facility staff will be able to enter data on PrEP services into the system in a timely manner, analyze the data, and use it for program improvement.
  • Gallery
    • HIV testing services (HTS) Data Quality Assessments and Improvement DQAIs
    • Interagency cervical cancer on-site mentorships
    • Orientation in KP tracker-Soroti
    • TDY from CDC headquarters visit to METS
    • M&E orientation meetings for new Implementing Partners
    • Planning meeting for Cross Border Data Sharing-Busia

View on METS

Continue Reading

Trending